Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

RLMD Relmada Therapeutics Inc

3,49

0,00 (0,00%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Relmada Therapeutics Charts.

News Relmada Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat
Dienstag 19 März 2024 (2 Monate vor) • IH Market News

Form 144 - Report of proposed sale of securities
Dienstag 20 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 11 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 4 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 3 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere Relmada Therapeutics Inc News-Artikel

Emmaus Life Sciences

Apollo Investment

Dimensional Inflation pr...

Departure Bay Capital

Mackenzie US High Yield ...

Sg Etn Metaverse

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen